Julia G. Butchko - Net Worth and Insider Trading
Julia G. Butchko Net Worth
The estimated net worth of Julia G. Butchko is at least $13 Million dollars as of 2024-11-29. Julia G. Butchko is the Chief Development Officer of Immunovant Inc and owns about 440,959 shares of Immunovant Inc (IMVT) stock worth over $13 Million. Details can be seen in Julia G. Butchko's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Julia G. Butchko has not made any transactions after 2024-08-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Julia G. Butchko
Julia G. Butchko Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Julia G. Butchko owns 2 companies in total, including Immunovant Inc (IMVTU) , and Immunovant Inc (IMVT) .
Click here to see the complete history of Julia G. Butchko’s form 4 insider trades.
Insider Ownership Summary of Julia G. Butchko
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
IMVTU | Immunovant Inc | 2020-09-11 | Chief Dev. & Tech. Officer |
IMVT | Immunovant Inc | 2024-08-21 | Chief Dev. & Tech. Officer |
Julia G. Butchko Latest Holdings Summary
Julia G. Butchko currently owns a total of 1 stock. Julia G. Butchko owns 440,959 shares of Immunovant Inc (IMVT) as of August 21, 2024, with a value of $13 Million.
Latest Holdings of Julia G. Butchko
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
IMVT | Immunovant Inc | 2024-08-21 | 440,959 | 28.73 | 12,668,752 |
Holding Weightings of Julia G. Butchko
Julia G. Butchko Form 4 Trading Tracker
According to the SEC Form 4 filings, Julia G. Butchko has made a total of 24 transactions in Immunovant Inc (IMVT) over the past 5 years, including 1 buys and 23 sells. The most-recent trade in Immunovant Inc is the sale of 3,027 shares on August 21, 2024, which brought Julia G. Butchko around $96,440.
Insider Trading History of Julia G. Butchko
- 1
Julia G. Butchko Trading Performance
GuruFocus tracks the stock performance after each of Julia G. Butchko's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Julia G. Butchko is 25.65%. GuruFocus also compares Julia G. Butchko's trading performance to market benchmark return within the same time period. The performance of stocks bought by Julia G. Butchko within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Julia G. Butchko's insider trading performs compared to the benchmark.
Performance of Julia G. Butchko
Julia G. Butchko Ownership Network
Julia G. Butchko Owned Company Details
What does Immunovant Inc do?
Who are the key executives at Immunovant Inc?
Julia G. Butchko is the Chief Dev. & Tech. Officer of Immunovant Inc. Other key executives at Immunovant Inc include 10 percent owner Roivant Sciences Ltd. , Chief Scientific Officer Michael James Elliott , and director & Chief Executive Officer Peter Salzmann .
Immunovant Inc (IMVTU) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Immunovant Inc (IMVTU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immunovant Inc (IMVTU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Immunovant Inc (IMVTU)'s detailed insider trading history can be found in Insider Trading Tracker table.
Immunovant Inc Insider Transactions
Julia G. Butchko Mailing Address
Above is the net worth, insider trading, and ownership report for Julia G. Butchko. You might contact Julia G. Butchko via mailing address: 320 W 37th Street, 3rd Floor, New York Ny 10016.